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In Western countries, better knowledge about patient-related determinants of treatment
adherence (medication and lifestyle) is needed to improve treatment adherence and out-
comes among hypertensive ethnic minority patients of African descent.
Objective
To identify patient-related determinants of adherence to lifestyle and medication recommen-
dations among hypertensive African Surinamese and Ghanaian patients with suboptimal
treatment results (SBP140) living in the Netherlands and how culturally appropriate hyper-
tension education (CAHE) influenced those determinants.
Methods
This study analysed data of 139 patients who participated in the CAHE trial. Univariate
logistic regression analysis was used to measure the association between patient-related
determinants (medication self-efficacy, beliefs about medication and hypertension, social
support, and satisfaction with care) and treatment adherence. We also tested whether
CAHE influenced the determinants.
Results
Medication self-efficacy and social support were associated with medication adherence at
baseline. At six months, more medication self-efficacy and fewer concerns about medica-
tion use were associated with improved medication adherence. Self-efficacy was also asso-
ciated with adherence to lifestyle recommendations at baseline. CAHE influenced patients’
illness perceptions by creating more understanding of hypertension, its chronic character,
and more concerns about the associated risks.
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Conclusion
In this high-risk population, health care providers can support medication adherence by
paying attention to patients’medication self-efficacy, the concerns they may have about
medication use and patients’ perceptions on hypertension. The CAHE intervention
improved patients’ perception on hypertension.
Introduction
Hypertension is a major risk factor for cardiovascular disease and especially stroke. [1] To
reduce the risk of cardiovascular disease, hypertensive patients must be treated appropriately,
either through lifestyle interventions alone or in combination with medication. [2] Treatment
of hypertension fails when patient-related barriers towards treatment are not recognised. A
better assessment and understanding of these barriers will allow optimal tailoring of interven-
tions. [3]
In Western countries, hypertension is more common among ethnic minority groups of
African descent than among whites. [4–6] Agyemang et al. reported that the prevalence of
hypertension among native Dutch adults was lower than among adults of African-Surinamese
and Ghanaian descent and that these ethnic minority groups had higher levels of hypertension
awareness. [7] Among treated hypertensive patients, blood pressure control rates were signifi-
cantly lower for the African Surinamese and the Ghanaians. [7–9] This demonstrates a need to
address barriers to blood pressure control among African Surinamese and Ghanaian patients
treated for hypertension. Poor adherence to treatment recommendations (medication and life-
style) has been identified as a major modifiable cause of differences in blood pressure control
rates in general [10, 11] and for those who belong to ethnic minority groups in particular [12,
13]. Knowledge of the relation between patient-related barriers and adherence could be used to
enhance treatment-adherence among patients with hypertension. [11]
Since studies in several countries have shown that adherence to hypertension treatment rec-
ommendations is generally lower among disadvantaged populations, such as ethnic minority
groups, it has been hypothesised that patients who belong to these groups may benefit from
culturally tailored educational approaches. [14–17] Additionally, cultural factors have been
shown to influence patients’ beliefs and practices concerning hypertension. [18–21] We have
previously developed a protocol for culturally adapted hypertension education (CAHE) to sup-
port adherence to lifestyle and medication recommendations and blood pressure control in
hypertensive patients of African descent. [22] The protocol combines the principles of motiva-
tional interviewing (5 A’s; i.e. Ask, Assess, Advise, Assist, and Arrange) [23] with those from
Arthur Kleinmans’ model. Kleinmans’ model proposes that patient perceptions of disease and
treatment can differ substantially from those of their healthcare providers. [24] The protocol
focuses on asking essential questions to generate understanding by the patients about their
health beliefs and their own condition in a multi-cultural environment. The main goal of the
CAHE intervention was to improve patients’ health behaviour and, in turn, their blood pres-
sure. Using a cluster randomised controlled trial we showed that CAHE leads to a higher
reduction in diastolic blood pressure (DBP) (5.73 mmHg vs. 1.70 mmHg) and better adherence
to lifestyle recommendations among African-Surinamese and Ghanaian patients with uncon-
trolled hypertension when compared to standard care. [22, 25]
Research based on models of health behaviour has provided evidence that adherence to
treatment is a self-regulatory process and that patients’ ideas about their illness (the
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consequence, timeline, personal-control, treatment-control and identity) and medications are
predictive of adherence to medication and lifestyle recommendations. [18–21, 26] In addition,
several studies have shown that self-efficacy influences patients’ ability and skills to continue
treatment. [27–29] Also satisfaction with care and social support have been identified as factors
influencing adherence. [9, 18, 30–32] However, the pathway from patient education to adher-
ence (and hypertension control) is complex and still poorly understood. This study aims at
deepening our understanding of this pathway, in particular for the treatment of hypertension
in a migrant population at high risk of cardiovascular disease. We report for the first time focus
areas for the treatment of this population. To this end we performed a secondary analysis of
the CAHE trial with the aim to identify 1) the (best) subset of determinants that predicted
adherence to medication and lifestyle recommendations prior to the intervention, 2) how
changes in those determinants were associated with adherence to medication and lifestyle rec-
ommendations after the intervention (at six months), and 3) we evaluated the role of CAHE by
investigating to what extent this intervention had influenced any of the determinants of adher-
ence, and particularly those that were associated with an improvement in treatment adherence.
Methods
Study design
This study analyses data that were collected among participants who completed the CAHE
study. Full details of the design and methods of this cluster-randomised trial and the content of
CAHE intervention have been published previously. [22, 25] Briefly, the study tested the effect
of the CAHE intervention on blood pressure control and treatment adherence among Suri-
namese and Ghanaian patients with uncontrolled hypertension from four Dutch primary
health care centres (PHCC) in Southeast Amsterdam. PHCCs allocated to the control group
provided standard (guideline based) hypertension care to the study participants and PHCCs
allocated to the intervention group provided usual care and three nurse-led individual CAHE
sessions to study participants. [33] At the start of the intervention (t0) and after 6 months (t1),
BP and other physiological measures were assessed and information on self-reported adher-
ence to lifestyle and medication and patient-related determinants of adherence (perception on
medication and hypertension, self-efficacy, social support, satisfaction with care) was collected
through validated questionnaires. (Table A in S1 File) Socio-demographic data were obtained
at the start of the intervention. The research assistants who performed the baseline and follow-
up assessments received a specific training for the purpose of this study and were blinded to
the study conditions. [25] All data was entered into SPSS Data Entry 4.0 (Ref: SPSS Inc, Chi-
cago IL, USA).
For this paper we performed a stepwise analysis of 1) the association between background
characteristics and patient-related determinants of adherence and self-reported adherence to
medication and lifestyle recommendations at baseline, 2) the association between changes in
patient-related determinants of adherence and changes in self-reported adherence of medica-
tion and lifestyle recommendations at six months and 3) the influence of the CAHE interven-
tion on changes in patient-related determinants of adherence. (Fig 1)
Variables and outcome measurements
Adherence to lifestyle and medication recommendations. Self-reported adherence to
medication recommendations was assessed with the eight-itemMorisky medication adherence
scale (MMAS-8). [34] This scale has been well validated in several studies among African-
American populations. [9, 35–37] The MMAS-8 asks patients to respond with ‘‘yes” or ‘‘no” to
a set of 7 questions and to one 5-point Likert scale question. The score for full adherence is 8,
Adherence to Treatment Recommendations and the Role of Education
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with lower scores indicating a poorer level of adherence with a lower boundary of zero. In this
study patients were described as non-adherent if they had an MMAS-8 score< 6 and as adher-
ent if their score was 6. When patients had become more adherent between T0 and T1 or
remained on the maximum score, they were categorised as ‘improved adherence’.
Self-reported adherence to lifestyle recommendations was assessed with a three-item scale
derived from the Morisky scale. [38] This scale contains three questions: 1) Have you been
advised by your PN/GP about smoking, nutrition, alcohol, weight control and/or physical
activity (Yes/No)? 2) If yes, what advice was given? 3) To what extent did you follow this advice
(range: never (1)–always (4))? On the basis of answers to these questions a composite score for
adherence to lifestyle recommendations was computed (range: 1–4). Patients with scores 1 and
2 were categorised as non-adherent and those with scores 3 and 4 were categorised as adherent
to lifestyle recommendations. When patients had become more adherent between T0 and T1
or remained on the maximum score, they were categorised as ‘improved adherence’. (Results of
a psychometric analysis of these outcome measures are shown in Tables D and E in S1 File).
Background characteristics and patient-related determinants of adherence. Self-
reported data on age, gender, educational level, financial status, duration of hypertension, and
years living in the Netherlands were collected at the start of the study, to describe background
characteristics of the study sample. (Table B in S1 File)
The following five measures were used to obtain information on potential patient-related
determinants of adherence (Table A in S1 File):
Perceptions of hypertension were assessed with the Brief Illness Perceptions Questionnaire
(IPQ-brief). The validity and the reliability of this questionnaire is well established The IPQ-
brief asks patients to provide information about 8 dimensions of illness (hypertension) that
can be answered on a 5-point Likert scale. Five dimensions are related to cognitive illness rep-
resentations (the perceived consequence, timeline, personal-control, treatment-control and
identity), two dimensions are related to emotional representations (respondents’ emotions and
concerns about the illness) and one dimension is related to illness comprehensibility (coher-
ence). [39] Separate scores for the 8 dimensions of illness perception and an overall score were
computed. The scores represent the degree to which the illness is perceived as threatening
(high scores) or benign (lower scores).
Fig 1. A schematic overview of the scope of this study. Fig 1 legend: A Schematic overview of the scope of this study and the study of Beune et al. [22]
Beune et al. showed positive correlations (solid arrows) of the CAHE intervention with adherence to lifestyle recommendations. Additionally, CAHE was
shown to lower diastolic blood pressure (blunt arrows). The dashed arrows indicate the research questions of this study. Research question 1 and 2 analyse
which determinants are associated with adherence to medication and lifestyle recommendations. Research question 3 answers which determinants the
CAHE intervention influences in order to increase adherence to medication and lifestyle recommendations.
doi:10.1371/journal.pone.0133560.g001
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Medication self-efficacy was assessed with the Medication Adherence Self-Efficacy Scale
(MASES-R). This scale shows good internal consistency, predictive validity, and convergent
validity in African-American patients with hypertension. [40] The patients’ confidence in their
ability to take medicine on time in various situations is measured with 13 questions, that can
be answered on a 4-point Likert scale. [40] Scores were totalled and the mean score reflects the
amount of medication self-efficacy, with higher scores designating higher self-efficacy.
Beliefs about medication were assessed with the ten-item Beliefs about Medicines Question-
naire (BMQ). [26] This instrument has good internal consistency and validity. [41, 42] The
first scale (Specific-necessity) of this questionnaire assesses hypertensive patients’ beliefs about
how necessary it is to take medications in order to improve/maintain their health. The second
scale (Specific-concern) assesses respondents’ “concerns” about potential adverse conse-
quences from taking their medications. The BMQ uses 5-point Likert questions ranging from 1
= “strongly disagree” to 5 = “strongly agree”. The respondents’ scores on each item were
totalled. Higher scores indicate stronger beliefs about the necessity of taking medicines and
concerns about adverse effects of medications.
The amount of Social Support patients experienced when dealing with their condition was
assessed using the validated 12-item Duke Social Support Scale (DUSOCS). [43] As demon-
strated by previous studies in hypertensive African-American patients, this scale has good
validity and reliability [35] DUSOCS is divided into two subscales: social support from family
(6-item scale) and social support from others than family (5-item scale). A higher total score
reflects more social support. The open question that is used in DUCOCS was not taken into
account in our analysis.
Satisfaction with care was measured using five items of the Consumer Quality Index-Diabe-
tes [44] and five items of the Quote Migrant. [45] Similar Consumer Quality Index instruments
have demonstrated good construct and discriminating validity and internal consistency in pre-
vious studies [46, 47] The Quote Migrant has been developed to measure the quality of care
experienced by migrants groups in the Netherlands.[45] A higher score reflects a higher satis-
faction with care.
Statistical analysis
Data were analysed using SPSS version 19 (Ref: SPSS Inc, Chicago IL, USA). The distributions
of continuous data were graphically assessed. Means and standard deviations were reported for
normally distributed data and medians and quartiles for non-normal distributed data.
Univariate logistic regression analysis was conducted to assess the association between each
determinant of adherence and each outcome variable (adherence to medication or lifestyle rec-
ommendations). Since the number of participants in the study was low, relative to the number of
measured determinants, [25] a p-value of 0.3 in the univariate analysis was used as an upper
threshold for inclusion in the multivariate logistic regression model. Using a stepwise backward
(LR) method, variables were selected for the final model. Only determinants that were statistically
significant (p< 0.05) contributors to the multivariate model were considered to be related to
adherence. The same procedure was used to examine the association between changes in deter-
minants of adherence and changes in adherence to medication and lifestyle recommendations.
To assess the influence of the CAHE intervention on the determinants of adherence we
compared the change in the determinants between the intervention and the control group.
Scores were compared using a chi-square test for categorical data and an independent t-test for
normally distributed continuous data.
The study protocols were approved by the medical ethics committee of the Academic Medi-
cal Center in Amsterdam (protocol ID MEC 09/070 # 09.17.0725) and CCMO
Adherence to Treatment Recommendations and the Role of Education
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(NL27507.018.09). This trial is registered at the ISRCTN Register under registration number
ISRCTN35675524 (http://www.controlled-trials.com/ISRCTN35675524). In accordance with
the Declaration of Helsinki, written informed consent was obtained from all patients.
Results
Description of the population
Patients’ background characteristics at baseline are shown in Table B in S1 File. The average
age of the patients was 53.9±9.8 years, and 47.5% were male. Table 1 shows that at the start of
the intervention 58.0% and 64.7% of the patients were categorised as adherent to medication
and lifestyle recommendations, respectively. Patients who were adherent to medication recom-
mendations reported a longer duration of stay in the Netherlands (mean difference: 4.5 years
(95% CI: 0.68–8.3) and less financial difficulties (mean difference: 0.17 (95% CI: 0.01–0.33)
compared to non-adherent patients. All other baseline differences between the adherent and
non-adherent group are marginal and summarised in Table B in S1 File. After six months dia-
stolic, but not systolic blood pressure was positively correlated with adherence to medication
and lifestyle recommendations. (Table C in S1 File)
Treatment adherence and determinants of adherence
Association between treatment adherence at the start of the intervention and back-
ground characteristics and patient-related determinants of adherence. At baseline patients







Adherence Adherent to medication, n (%) 65 (58.0%) 79 (65.3%)
Adherent to lifestyle advice, n (%) 75 (64.7%) 87 (75.5%)
Positive change in medication adherence, n
(%):
63 (57.3%)
Positive change in lifestyle adherence, n (%): 55 (56.7%)
Social support family, mean (±SD) 39.5 (±28.3) 41.3 (±25.9) 0–100
Social support others, mean (±SD) 25.9 (±23.2) 29.3 (±23.8) 0–100
Illness perception Illness perception overall score (IPQ-Brief), mean
(±SD)
36.6 (±11.2) 34.3 (±10.2) 0–80
Per item: Consequences 5.0 (±3.1) 5.2 (±2.8) 0–10
Timeline 6.0 (±3.2) 6.6 (±3.0) 0–10
Personal-control 6.3 (±2.8) 7.4 (±2.1) 0–10
Treatment-control 7.4 (±2.3) 8.1 (±1.7) 0–10
Identity 4.1 (±3.1) 4.1 (±2.7) 0–10
Illness coherence 7.2 (±2.9) 7.5 (±2.7) 0–10
Emotions 5.0 (±3.4) 4.7 (±3.2) 0–10
Illness concerns 7.2 (±3.0) 6.9 (±2.9) 0–10
Medication self-efﬁcacy,mean (±SD) 3.4 (±0.7) 3.5 (±0.6) 0–4
Satisfaction with care Satisfaction with healthcare—CQI 18.4 (±2.4) 18.3 (±2.6) 6–20
Satisfaction with healthcare-Quote migrant 12.2 (±5.9) 13.1 (±5.7) 0–20
Beliefs about medication Concerns about medication use–BMQ Concerns 13.8 (±4.3) 13.6 (±4.4) 5–25
Necessity of medication use–BMQ Necessity 16.4 (±5.0) 16.3 (±4.7) 5–25
SD = Standard deviation
doi:10.1371/journal.pone.0133560.t001
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who were adherent to medication- and lifestyle recommendations reported higher medication
self-efficacy as compared to non-adherent patients (p<0.001 and p = 0.026, resp.). Patients
who were adherent to medications experienced less social support from non-family members
as compared to non-adherent patients (p = 0.046). (Table 2) Adherence was not significantly
associated with the other potential patient-related determinants.
Association between changes in patient-related determinants of adherence and changes
in treatment adherence at six months. Table 3 shows that patients who showed an higher
level of medication self-efficacy after six months were more likely to report an improvement in
adherence to medication than those who did not (p = 0.031). Additionally, older patients were
more likely to show an improvement in medication adherence than younger patients
(p = 0.033). Patients who were more concerned about their medication use at baseline (BMQ-
concern) were less likely to report an improvement in medication adherence. In this group the
reported level of medication adherence remained low or decreased (p = 0.04). There were no
significant associations between changes in determinants of adherence and changes in adher-
ence to lifestyle recommendations.
Table 2. Association between adherence to medication and lifestyle recommendations and determi-
nants at start of intervention.
Determinants of medication adherence *1 Exp. Β (95% Conﬁdence Interval) P-value
Medication self-efﬁcacy 7.62 (3.00–19.35) <0.001
Social support—others 0.98 (0.96–1.00) 0.046
Determinants of lifestyle adherence *2 Exp. Β (95% Conﬁdence Interval) P-value
Medication self-efﬁcacy 2.16 (1.10–4.27) 0.03
Social support—others 1.02 (1.00–1.04) 0.10
*1 Multiple logistic regression analysis, backward LR. Model included variables: Medication self-efﬁcacy,
Illness perception overall score (IPQ-brief), Social support–family, Social support–others, Satisfaction-
healthcare. And not modiﬁable factors: age, ﬁnancial status, duration of hypertension, and years in
Netherland.
*2 Multiple logistic regression analysis, backward LR. Model included variables: Medication self-efﬁcacy,
Social support—others, Social support–family, satisfaction healthcare. And non-modiﬁable factors: Age
and educational level.
doi:10.1371/journal.pone.0133560.t002
Table 3. Associations between changes in adherence to medication and lifestyle recommendations
and changes in determinants of adherence at six months.
Determinants of medication adherence*1 Exp. Β (95% Conﬁdence Interval) P-value
Change in medication self-efﬁcacy 2.64 (1.09–6.39) 0.03
Change in concerns about medication use 0.89 (0.79–0.99) 0.04
Change in illness perceptions 1.04 (0.99–1.09) 0.10
Age 1.05 (1.00–1.11) 0.03
Determinants of lifestyle adherence *2 Exp. Β (95% Conﬁdence Interval) P-value
Change in medication self-efﬁcacy 1.56 (0.69–3.53) 0.24
*1 Multiple logistic regression analysis, backward LR. Model included variables: the change in medication
self-efﬁcacy, Illness perception overall score (IPQ-brief)-, and beliefs about medication- (BMQ-concern).
And non-modiﬁable factors: age, educational level and duration of hypertension.
*2 Multiple logistic regression analysis, backward LR. Model included variables: the change in medication
self-efﬁcacy. And non-modiﬁable factors: Age and educational level.
doi:10.1371/journal.pone.0133560.t003
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Influence of the CAHE intervention on patient-related determinants of adherence.
Table 4 shows that patients who had received CAHE reported a better understanding of hyper-
tension (IPQ-coherence (p = 0.028)), and more concerns about their hypertension than those
in the control group (IPQ-illness concern (p = 0.033) and they better realized that hypertension
is a chronic disease (p = 0.05)). However, there were no other statistically significant differences
in scores on patient-related determinants of adherence between the two groups.
Discussion and Conclusion
This study examined the pathway from patient education (CAHE) to adherence via patient-
related determinants of adherence, among treated hypertensive patients of African descent
from Dutch general practices with suboptimal treatment control (Fig 1). We found that medi-
cation self-efficacy and social support were the main determinants of adherence to lifestyle and
medication recommendations at baseline. An increase in self-efficacy and a decrease in concern
about medication use during the course of the clinical trial, led to an improvement in medica-
tion adherence. We found that the CAHE intervention did not significantly influence the afore-
mentioned determinants of adherence. However, CAHE did improve patients’ illness
perceptions, in terms of a better understanding of hypertension, more concerns about the asso-
ciated risks and more awareness of the chronic character of hypertension.
Comparison with other studies
This study demonstrates that patient’s medication self-efficacy positively influences adherence
to antihypertensive medication. Similar results have been reported by studies on adherence
[27, 48]: The more confident patients are that they will be able to take their medications in dif-
ferent situations, the more likely they are to be adherent. This is also consistent with findings
from studies on other chronic diseases, such as rheumatoid arthritis, asthma, depression, [28,
32, 49, 50] and with studies on hypertension in African American patients. [27, 51, 52]
Table 4. The mean changes in patient-related determinants of adherence for patients allocated to CAHE (intervention) or usual care (control).
Variable Mean (SD) P value Mean difference (95% CI)
Intervention Control
Change in social Support 2.78 (18.66) 2.99 (22.25) 0.95 -0.20 (-7.22–6.81)
Change in concerns about medication use -0.45 (3.94) -0.33 (4.23) 0.88 -0.11 (-1.68–1.45)
Change in necessity of medication use 0.38 (4.68) -0.43 (3.73) 0.31 0.81 (-0.77–2.40)
Change in satisfaction healthcare 0.12 (2.43) -0.39 (2.61) 0.25 0.51 (-0.35–1.36)
Change in satisfaction migrant 1.20 (3.48) 0.55 (4.11) 0.33 0.64 (-0.66–1.95)
Change in self-efﬁcacy 0.085 (0.68) 0.088 (0.44) 0.98 -0.002 (-0.22–0.22)
Change in illness perceptions overall -1.88 (9.13) -3.18 (9.43) 0.42 1.30 (-1.87–4.47)
Change in consequence 0.41 (2.80) -0.15 (2.85) 0.31 0.55 (-0.40–1.51)
Change in timeline 0.94 (2.51) 0.15 (2.85) 0.05 0.79 (0.00–1.59)*
Change in personal-control 1.34 (3.07) 0.82 (2.77) 0.25 0.51 (-0.48–1.51)
Change in treatment-control 0.97 (2.32) 0.54 (2.54) 0.31 0.43(-0.40–1.25)
Change in identity 0.33 (2.93) -0.44 (3.29) 0.15 0.77 (-0.28–1.83)
Change in coherence 0.94 (3.12) -0.22 (3.02) 0.03 1.16 (0.12–2.20)*
Change in emotions -0.06 (3.36) -0.72 (3.10) 0.23 0.66 (-0.43–1.76)
Change in illness concern 0.14 (2.74) -0.87 (2.77) 0.03 1.01 (0.08–1.94)*
Comparison of the CAHE and usual care groups of their change in determinants at the start of the intervention and after 6 months
doi:10.1371/journal.pone.0133560.t004
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Our study suggests that adherent patients experienced a lower level of social support from
people outside their families. Interestingly, this contrasts findings by Maguire et al., [53] who
showed that adherent patients experience greater levels of social support. Although this last
finding seems plausible, previous studies have shown that, especially in ethnic minority popu-
lations that were the focus of this study, talking about ones’ health problems to people outside
the immediate family might be a taboo. Patients may fear that outsiders will view the fact that
they have hypertension as an indication that their family suffers from financial problems or
stress. [19, 54] This might explain the contrasting findings of Maguire et al. [53] and the pres-
ent study.
In line with our finding that a lower level of concerns about medications is associated with
improved adherence, a recent meta-analysis of 94 studies, that used the BMQ, also demon-
strated that people with fewer concerns about their treatment show higher adherence to treat-
ment. [55] This means it is important for health care providers to discuss cultural specific
concerns about antihypertensives with patients from ethnic minority populations. Concerns
about the side effects of medication, such as loss of sexual performance, or preference for tradi-
tional remedies, [18] may offer one possible explanation for the low rates of hypertension con-
trol found among African-Surinamese and Ghanaian men recently in the Netherlands. [56]
The study of Serour et al. [57] concluded that stress was mostly reported as the determinant
for adherence to lifestyle recommendations. However, information on stress was not present in
our data set. Since none of our examined determinants of adherence we examined in this study
significantly explains the variation in adherence to lifestyle recommendations, stress (as
reported by Serour et al. [57]) remains the only known determinant for lifestyle adherence.
Study weaknesses and strengths
To our knowledge this is the first study that examines patient-related determinants of hyper-
tension treatment adherence among ethnic minority patients of African descent with uncon-
trolled blood pressure outside the US. In the CAHE study self-report instruments for assessing
adherence to medications and lifestyle recommendations have been used. The self-reported
format to acquire data has general advantages and disadvantages. [58] To obtain a high level of
reliability all determinants were tested using multiple questions with validated questionnaires
(Table A in S1 File).Questions regarding lifestyle adherence were an exception since this scale
was not validated. [25] However, the normal distributed outcomes ‘lifestyle adherence’ and
‘change in lifestyle adherence’ both provide Cronbach’s alpha that ensure enough confidence
to use this instrument. (Tables D and E in S1 File)
The used Morisky scale for assessing lifestyle adherence is of a complex nature since it sum-
marizes multiple items of lifestyle adherence (smoking, nutrition, alcohol, weight control and/or
physical activity). Preferably the association of each item with the possible determinants would
be tested individually on each item, which is unfeasible due to the limited population size.
Since this study is a secondary analysis, some measurements and instruments are not the
best imaginable fit to obtain the answers to our research questions. Considering ‘medication
adherence’ the actual medication intake would be a preferred measure, and also for ‘lifestyle
adherence’ a more objective measurement would be preferred.
The self-efficacy reported for both lifestyle and mediation adherence is measured with the
MASES-R. Since MASES-R is tailored to measure medication adherence, we can’t state that
CAHE is not associated with lifestyle adherence self-efficacy. A possible explanation that
CAHE did not affect medication-self efficacy is the limited room for improvement, as the level
of medication self-efficacy was already very high at the start of the intervention (3.4 out of
4-point Likert scales).
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The BMQ used to measure beliefs about medication was shown to be insufficient to capture
cultural variations in medication beliefs. [55] As CAHE particularly targets culturally specific
perceptions of medications the BMQmight be unsuitable to evaluate CAHE.
We have chosen the MMAS-8 for measuring medication adherence because the instrument
has been well validated and had reported good predictive power. [9, 35–37] However it should
be noted that some studies warn for overestimation of adherence by MMAS-8. [59]
Due to the relatively low numbers of participants we were forced to reduce the number of
determinants that could be taken into consideration within our analysis. By excluding some of
the determinants based on univariate relations, we also excluded interaction terms involving
these determinants.
Practice implications
The development of more effective methods for addressing treatment adherence among hyper-
tensive patients of African descent is a priority for research and practice in Western countries.
[7, 60] Our study suggest that interventions to support optimal adherence to prescribed medi-
cations are likely to be more successful in this population if health care professionals discuss
patients’ concerns about medications and confidence in the ability to take medication (self-effi-
cacy). While a previous study already has shown that CAHE can lead to greater adherence to
lifestyle changes, [11, 18, 19] the present study suggests that this educational approach also
leads to a better understanding of hypertension, and increase in concerns about the associated
risks of hypertension and more awareness that hypertension can be controlled but not cured.
Education should be targeted at the understanding that hypertension is not a disease in itself,
but treatment is necessary to prevent events in the future, events that can be avoided. This is
important since patients often stop taking medication or stop implementing lifestyle changes
when their blood pressure is regulated as they believe hypertension is cured. These misconcep-
tions about the nature and course of hypertension can negatively affect treatment adherence.
[11, 18, 19] A possible option to tackle misconceptions and concerns about hypertension are
shared medical appointments, which are shown to have a positive impact. [61, 62] As concerns
about medication (and especially side-effects) lead to poor adherence and patients often do not
mention (fear of) side-effects by themselves, doctors should discuss side-effects on a regular
basis.
Conclusion
Our study deepens the understanding of the pathway from patient education (CAHE) to
adherence to lifestyle and medication recommendations for hypertension in ethnic minority
patients of African descent with uncontrolled blood pressure. Firstly, more medication self-effi-
cacy and less social support from people outside the family are associated with higher adher-
ence to medication and lifestyle recommendations. Secondly, improvement in medication self-
efficacy and decrease in concerns about medication is associated with increased medication
adherence. Thirdly, the CAHE intervention appears to have a beneficial effect on patients’ ill-
ness perceptions, by contributing to a better understanding of hypertension and concerns
about the associated risks, but not on patients’ medication self-efficacy or their concerns about
medication.
Supporting Information
S1 File. Table A: Instruments for measuring patient-related determinants. Table B: Patient
Characteristics at the start of the intervention (N = 139). Table C: Association between
blood pressure and adherence. Table D: Extra information about outcome measure
Adherence to Treatment Recommendations and the Role of Education
PLOS ONE | DOI:10.1371/journal.pone.0133560 August 12, 2015 10 / 14
‘Lifestyle adherence’. Table E: Extra information about outcome measure ‘Change in Life-
style adherence’.
(DOC)
S1 Text. Dutch abstract.
(DOC)
Acknowledgments
We acknowledge Jacob Mohr for his help by the statistical analysis.
Author Contributions
Conceived and designed the experiments: JH EB. Performed the experiments: JH EB JM NvD.
Analyzed the data: JM NvD. Contributed reagents/materials/analysis tools: HvW DJ. Wrote
the paper: JH EB HvW JM DJ NvD.
References
1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, BohmM, et al. 2013 ESH/ESCGuidelines
for the management of arterial hypertension: the Task Force for the management of arterial hyperten-
sion of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Journal of hypertension. 2013; 31(7):1281–357. doi: 10.1097/01.hjh.0000431740.32696.cc PMID:
23817082.
2. World Health O. Prevention of Cardiovascular Disease. Pocket Guidelines for asssessement and man-
agement of cardiovascular risk. WHO press. 2007.
3. Nieuwlaat R, Schwalm JD, Khatib R, Yusuf S. Why are we failing to implement effective therapies in
cardiovascular disease? European heart journal. 2013; 34(17):1262–9. doi: 10.1093/eurheartj/ehs481
PMID: 23376448.
4. Agyemang C, Bhopal R. Is the blood pressure of people from African origin adults in the UK higher or
lower than that in European origin white people? A review of cross-sectional data. JHumHypertens.
2003; 17(8):523–34. doi: 10.1038/sj.jhh.1001586 1001586 [pii].
5. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hyperten-
sion, 1988–2008. JAMA. 2010; 303(20):2043–50. doi: 10.1001/jama.2010.650 PMID: 20501926.
6. Chobanian AV, Bakris GL, Black HR, CushmanWC, Green LA, Izzo JL Jr., et al. The Seventh Report
of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood
Pressure: the JNC 7 report. JAMA. 2003; 289(19):2560–72. doi: 10.1001/jama.289.19.2560 PMID:
12748199.
7. Agyemang C, Kieft S, Snijder MB, Beune EJ, van den Born BJ, Brewster LM, et al. Hypertension control
in a large multi-ethnic cohort in Amsterdam, The Netherlands: The HELIUS study. Int J Cardiol. 2015;
183C:180–9. doi: 10.1016/j.ijcard.2015.01.061 PMID: 25679990.
8. Agyemang C, Attah-Adjepong G, Owusu-Dabo E, De-Graft Aikins A, Addo J, Edusei AK, et al. Stroke in
Ashanti region of Ghana. Ghana medical journal. 2012; 46(2 Suppl):12–7. PMID: 23661812; PubMed
Central PMCID: PMC3645146.
9. Schoenthaler A, Chaplin WF, Allegrante JP, Fernandez S, Diaz-Gloster M, Tobin JN, et al. Provider
communication effects medication adherence in hypertensive African Americans. PatientEducCouns.
2009; 75(2):185–91. S0738-3991(08)00527-2 [pii];doi: 10.1016/j.pec.2008.09.018
10. De GS, Sabate E. Adherence to long-term therapies: evidence for action. EurJCardiovascNurs. 2003; 2
(4):323. S1474515103000914 [pii].
11. Khatib R, Schwalm JD, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider
barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of
qualitative and quantitative studies. PLoS One. 2014; 9(1):e84238. doi: 10.1371/journal.pone.0084238
PMID: 24454721; PubMed Central PMCID: PMC3893097.
12. Lewis LM, Ogedegbe C, Ogedegbe G. Enhancing adherence of antihypertensive regimens in hyperten-
sive African-Americans: current and future prospects. ExpertRevCardiovascTher. 2012; 10(11):1375–
80. doi: 10.1586/erc.12.138
Adherence to Treatment Recommendations and the Role of Education
PLOS ONE | DOI:10.1371/journal.pone.0133560 August 12, 2015 11 / 14
13. Odedosu T, Schoenthaler A, Vieira DL, Agyemang C, Ogedegbe G. Overcoming barriers to hyperten-
sion control in African Americans. CleveClinJMed. 2012; 79(1):46–56. 79/1/46 [pii];doi: 10.3949/ccjm.
79a.11068
14. Cooper LA, Hill MN, Powe NR. Designing and evaluating interventions to eliminate racial and ethnic
disparities in health care. JGenInternMed. 2002; 17(6):477–86. jgi10633 [pii].
15. Netto G, Bhopal R, Lederle N, Khatoon J, Jackson A. How can health promotion interventions be
adapted for minority ethnic communities? Five principles for guiding the development of behavioural
interventions. Health PromotInt. 2010; 25(2):248–57. daq012 [pii];doi: 10.1093/heapro/daq012
16. Connell P, Wolfe C, McKevitt C. Preventing stroke: a narrative review of community interventions for
improving hypertension control in black adults. Health SocCare Community. 2008; 16(2):165–87.
HSC737 [pii];doi: 10.1111/j.1365-2524.2007.00737.x
17. Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on
medication adherence. Journal of clinical hypertension. 2006; 8(3):174–80. PMID: 16522994.
18. Beune EJ, Haafkens JA, Agyemang C, Schuster JS, Willems DL. How Ghanaian, African-Surinamese
and Dutch patients perceive and manage antihypertensive drug treatment: a qualitative study. JHyper-
tens. 2008; 26(4):648–56. doi: 10.1097/HJH.0b013e3282f4d20b 00004872-200804000-00008 [pii].
19. Beune EJ, Haafkens JA, Schuster JS, Bindels PJ. 'Under pressure': How Ghanaian, African-Surinam-
ese and Dutch patients explain hypertension. JHumHypertens. 2006; 20(12):946–55. 1002094 [pii];doi:
10.1038/sj.jhh.1002094
20. Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medica-
tion adherence in hypertensive African Americans: a qualitative study. EthnDis. 2004; 14(1):3–12.
21. Kressin NR, Orner MB, Manze M, Glickman ME, Berlowitz D. Understanding contributors to racial dis-
parities in blood pressure control. CircCardiovascQualOutcomes. 2010; 3(2):173–80. CIRCOUT-
COMES.109.860841 [pii];doi: 10.1161/CIRCOUTCOMES.109.860841
22. Beune EJ, Moll van Charante EP, Beem L, Mohrs J, Agyemang CO, Ogedegbe G, et al. Culturally
adapted hypertension education (CAHE) to improve blood pressure control and treatment adherence in
patients of African origin with uncontrolled hypertension: cluster-randomized trial. PLoS One. 2014; 9
(3):e90103. doi: 10.1371/journal.pone.0090103 PMID: 24598584; PubMed Central PMCID:
PMC3943841.
23. Whitlock EP, Orleans CT, Pender N, Allan J. Evaluating primary care behavioral counseling interven-
tions: an evidence-based approach. AmJPrevMed. 2002; 22(4):267–84. S0749379702004154 [pii].
24. Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and
cross-cultural research. AnnInternMed. 1978; 88(2):251–8.
25. Haafkens JA, Beune EJ, Moll van Charante EP, Agyemang CO. A cluster-randomized controlled trial
evaluating the effect of culturally-appropriate hypertension education among Afro-Surinamese and
Ghanaian patients in Dutch general practice: study protocol. BMCHealth ServRes. 2009; 9:193. 1472-
6963-9-193 [pii];doi: 10.1186/1472-6963-9-193
26. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treat-
ment in chronic physical illness. JPsychosomRes. 1999; 47(6):555–67. S0022399999000574 [pii].
27. Warren-Findlow J, Seymour RB, Brunner Huber LR. The association between self-efficacy and hyper-
tension self-care activities among African American adults. JCommunity Health. 2012; 37(1):15–24.
doi: 10.1007/s10900-011-9410-6
28. Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depres-
sive symptoms and medication adherence among hypertensive African Americans. Health EducBehav.
2009; 36(1):127–37. 1090198107309459 [pii];doi: 10.1177/1090198107309459
29. Schofield P, Saka O, Ashworth M. Ethnic differences in blood pressure monitoring and control in south
east London. BrJGenPract. 2011; 61(585):190–6. doi: 10.3399/bjgp11X567126
30. Gallant MP, Spitze G, Grove JG. Chronic illness self-care and the family lives of older adults: a synthetic
review across four ethnic groups. JCrossCultGerontol. 2010; 25(1):21–43. doi: 10.1007/s10823-010-
9112-z
31. Kronish IM, Leventhal H, Horowitz CR. Understanding minority patients' beliefs about hypertension to
reduce gaps in communication between patients and clinicians. JClinHypertens(Greenwich). 2012; 14
(1):38–44. doi: 10.1111/j.1751-7176.2011.00558.x
32. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical
treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of
internal medicine. 2000; 160(14):2101–7. PMID: 10904452.
33. Smulders YM, Burgers JS, Scheltens T, van Hout BA, Wiersma T, Simoons ML, et al. Clinical practice
guideline for cardiovascular risk management in the Netherlands. The Netherlands journal of medicine.
2008; 66(4):169–74. PMID: 18424866.
Adherence to Treatment Recommendations and the Role of Education
PLOS ONE | DOI:10.1371/journal.pone.0133560 August 12, 2015 12 / 14
34. Morisky DE, Ang A, Krousel-Wood M,Ward HJ. Predictive validity of a medication adherence measure
in an outpatient setting. Journal of clinical hypertension. 2008; 10(5):348–54. PMID: 18453793;
PubMed Central PMCID: PMC2562622.
35. Ogedegbe G, Schoenthaler A, Richardson T, Lewis L, Belue R, Espinosa E, et al. An RCT of the effect
of motivational interviewing on medication adherence in hypertensive African Americans: rationale and
design. ContempClinTrials. 2007; 28(2):169–81. S1551-7144(06)00046-2 [pii];doi: 10.1016/j.cct.2006.
04.002
36. Schoenthaler A, Allegrante JP, Chaplin W, Ogedegbe G. The effect of patient-provider communication
on medication adherence in hypertensive black patients: does race concordance matter? Annals of
behavioral medicine: a publication of the Society of Behavioral Medicine. 2012; 43(3):372–82. doi: 10.
1007/s12160-011-9342-5 PMID: 22270266; PubMed Central PMCID: PMC3665951.
37. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treat-
ment in an inner-city minority population. American journal of public health. 1992; 82(12):1607–12.
PMID: 1456334; PubMed Central PMCID: PMC1694541.
38. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of
medication adherence. MedCare. 1986; 24(1):67–74.
39. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. JPsycho-
somRes. 2006; 60(6):631–7. S0022-3999(05)00491-5 [pii];doi: 10.1016/j.jpsychores.2005.10.020
40. Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication
adherence self-efficacy scale (MASES) in hypertensive African Americans. JBehavMed. 2008; 31
(6):453–62. doi: 10.1007/s10865-008-9170-7
41. Theunissen NC, de Ridder DT, Bensing JM, Rutten GE. Manipulation of patient-provider interaction:
discussing illness representations or action plans concerning adherence. Patient education and
counseling. 2003; 51(3):247–58. PMID: 14630381.
42. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and
treatment beliefs. Journal of human hypertension. 2004; 18(9):607–13. doi: 10.1038/sj.jhh.1001721
PMID: 15029218.
43. Parkerson GR Jr., BroadheadWE, Tse CK. Validation of the Duke Social Support and Stress Scale.
FamMed. 1991; 23(5):357–60.
44. Consumer Quality Index-diabetes. Nivel. 2009-09-06; Utrecht.
45. Harmsen JA, Bernsen RM, Bruijnzeels MA, Meeuwesen L. Patients' evaluation of quality of care in gen-
eral practice: what are the cultural and linguistic barriers? Patient education and counseling. 2008; 72
(1):155–62. doi: 10.1016/j.pec.2008.03.018 PMID: 18485657.
46. Stubbe JH, Brouwer W, Delnoij DM. Patients' experiences with quality of hospital care: the Consumer
Quality Index Cataract Questionnaire. BMC ophthalmology. 2007; 7:14. doi: 10.1186/1471-2415-7-14
PMID: 17877840; PubMed Central PMCID: PMC2093924.
47. Stubbe JH, Gelsema T, Delnoij DM. The Consumer Quality Index Hip Knee Questionnaire measuring
patients' experiences with quality of care after a total hip or knee arthroplasty. BMC health services
research. 2007; 7:60. doi: 10.1186/1472-6963-7-60 PMID: 17462084; PubMed Central PMCID:
PMC1876799.
48. Criswell TJ, Weber CA, Xu Y, Carter BL. Effect of self-efficacy and social support on adherence to anti-
hypertensive drugs. Pharmacotherapy. 2010; 30(5):432–41. doi: 10.1592/phco.30.5.432 PMID:
20411995; PubMed Central PMCID: PMC4073236.
49. van Es SM, Kaptein AA, Bezemer PD, Nagelkerke AF, Colland VT, Bouter LM. Predicting adherence to
prophylactic medication in adolescents with asthma: an application of the ASE-model. Patient educa-
tion and counseling. 2002; 47(2):165–71. PMID: 12191540.
50. Brus H, van de Laar M, Taal E, Rasker J, Wiegman O. Determinants of compliance with medication in
patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient education and
counseling. 1999; 36(1):57–64. PMID: 10036560.
51. Kressin NR, Wang F, Long J, Bokhour BG, Orner MB, Rothendler J, et al. Hypertensive patients' race,
health beliefs, process of care, and medication adherence. Journal of general internal medicine. 2007;
22(6):768–74. doi: 10.1007/s11606-007-0165-9 PMID: 17364243; PubMed Central PMCID:
PMC2219848.
52. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication
adherence self-efficacy scale in hypertensive African-American patients. JClinEpidemiol. 2003; 56
(6):520–9. S0895435603000532 [pii].
53. Maguire LK, Hughes CM, McElnay JC. Exploring the impact of depressive symptoms and medication
beliefs on medication adherence in hypertension—a primary care study. Patient education and
counseling. 2008; 73(2):371–6. doi: 10.1016/j.pec.2008.06.016 PMID: 18692978.
Adherence to Treatment Recommendations and the Role of Education
PLOS ONE | DOI:10.1371/journal.pone.0133560 August 12, 2015 13 / 14
54. Kohinor MJ, Stronks K, Haafkens JA. Factors affecting the disclosure of diabetes by ethnic minority
patients: a qualitative study among Surinamese in the Netherlands. BMC public health. 2011; 11:399.
doi: 10.1186/1471-2458-11-399 PMID: 21619571; PubMed Central PMCID: PMC3130672.
55. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adher-
ence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the
Necessity-Concerns Framework. PLoS One. 2013; 8(12):e80633. doi: 10.1371/journal.pone.0080633
PMID: 24312488; PubMed Central PMCID: PMC3846635.
56. Agyemanga CSK, Snijdera MB, Beunea EJ, van den Bornb BJ, Brewsterb LM, Ujcic-Voortmanc JJ,
et al. Hypertension control in a large multi-ethnic cohort in Amsterdam, the Netherlands: The HELIUS
study. International Journal of Cardiology. 2015;doi: 10.1016/j.ijcard.2015.01.061(Available online 27
January 2015).
57. Serour M, Alqhenaei H, Al-Saqabi S, Mustafa AR, Ben-Nakhi A. Cultural factors and patients' adher-
ence to lifestyle measures. The British journal of general practice: the journal of the Royal College of
General Practitioners. 2007; 57(537):291–5. PMID: 17394732; PubMed Central PMCID:
PMC2043336.
58. Practitioners RCoG. Medicines Adherence: Involving Patients in Decisions About Prescribed Medi-
cines and Supporting Adherence. NICE Clinical Guidelines, No 76. 2009;(National Collaborating Cen-
tre for Primary Care (UK)):Par. 7.3.
59. Ye S, Krupka DJ, Davidson KW. Diagnosing medication non-adherence in a patient with myocardial
infarction. Frontiers in psychology. 2012; 3:267. doi: 10.3389/fpsyg.2012.00267 PMID: 22876236;
PubMed Central PMCID: PMC3411184.
60. Agyemang C, Bindraban N, Mairuhu G, Montfrans G, Koopmans R, Stronks K. Prevalence, awareness,
treatment, and control of hypertension among Black Surinamese, South Asian Surinamese andWhite
Dutch in Amsterdam, The Netherlands: the SUNSET study. JHypertens. 2005; 23(11):1971–7.
00004872-200511000-00009 [pii].
61. Bray P, Thompson D, Wynn JD, Cummings DM, Whetstone L. Confronting disparities in diabetes care:
the clinical effectiveness of redesigning care management for minority patients in rural primary care
practices. J Rural Health. 2005; 21(4):317–21. PMID: 16294654.
62. Rahaghi FF, Chastain VL, Benavides R, Ferrer G, Ramirez J, Mehta J, et al. Shared medical appoint-
ments in pulmonary hypertension. Pulm Circ. 2014; 4(1):53–60. doi: 10.1086/674883 PMID: 25006421;
PubMed Central PMCID: PMC4070761.
Adherence to Treatment Recommendations and the Role of Education
PLOS ONE | DOI:10.1371/journal.pone.0133560 August 12, 2015 14 / 14
